Zybio Inc. is a high-tech enterprise specialized in R&D, manufacture, sales and technical services of in vitro diagnostic reagents and equipment, with the headquarter and manufacturing center located in Chongqing, China.Zybio has more than 3,800 employees worldwide, of which R&D personnel account for more than 30% . Nearly 50% of R&D personnel have master's degree or above. The company compared to spend no less than 15% of sales revenue on its research and development.As a postdoctoral programme, Zybio is dedicated to attract more talents to focus on the cutting-edge technology in IVD field and take product research and development as the core driving force in the future’s continuous and rapid development. Zybio has established several R&D centers distributed in China, like Chongqing R&D center, Beijing R&D center, Guangzhou R&D center, Shenzhen R&D center, Nanjing R&D center Xiamen R&D center and Changchun R&D center. The company’s main product covers clinical chemistry, immunoassay, molecular diagnosis, POCT, hematology, microbiology, pathological and other diagnostic products. Till now, Zybio has obtained nearly 500 product registration certificates and nearly 60 invention patents. "Dedication To Accuracy", Zybio will continue to meet the various needs of customers, focus on innovation in IVD industry.